Charming Medical Ltd(MCTA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
No SEC XBRL data
This company has no XBRL financial filings on file with SEC EDGAR. Common for ADRs, recent IPOs, OTC-listed names, and foreign filers that haven't filed 20-F yet.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
MCTA Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Charming Medical Ltd (MCTA), a Healthcare sector company. MCTA is not currently included in 13F Pro's AI-ranked quality universe — this company has no xbrl financial filings on file with sec edgar. common for adrs, recent ipos, otc-listed names, and foreign filers that haven't filed 20-f yet. Top institutional holders of MCTA by reported 13-F value include UBS Group AG, GEODE CAPITAL MANAGEMENT,, JFS WEALTH ADVISORS,, based on the most recent SEC filings. MCTA trades on the Nasdaq exchange and files with the SEC under CIK 2035992. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MCTA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Charming Medical Ltd directly from SEC EDGAR.
Get alerted when MCTA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Charming Medical Ltd including:
Top Institutional Holders of MCTA
UBS Group AG
$732.4K24,949 shGEODE CAPITAL MANAGEMENT, LLC
$315.6K10,752 shJFS WEALTH ADVISORS, LLC
$0.005,850 sh
| Fund | Value | Shares |
|---|---|---|
| UBS Group AG | $732.4K | 24,949 |
| GEODE CAPITAL MANAGEMENT, LLC | $315.6K | 10,752 |
| JFS WEALTH ADVISORS, LLC | $0.00 | 5,850 |
More Healthcare Companies
View all Healthcare →Put MCTA on your watchlist
Track score changes the day Charming Medical Ltd files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MCTA a good stock to buy?
13F Pro's AI-powered analysis of Charming Medical Ltd (MCTA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MCTA are available on the MCTA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own MCTA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MCTA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Charming Medical Ltd's investment landscape.